SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008019
Filing Date
2017-11-02
Accepted
2017-11-02 16:34:14
Documents
71
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-20170930x10q.htm 10-Q 1986711
2 EX-31.1 clvs-20170930ex311a172e5.htm EX-31.1 19905
3 EX-31.2 clvs-20170930ex31226349b.htm EX-31.2 20145
4 EX-32.1 clvs-20170930ex321e1c277.htm EX-32.1 8013
5 EX-32.2 clvs-20170930ex322342114.htm EX-32.2 8394
  Complete submission text file 0001558370-17-008019.txt   7032454

Data Files

Seq Description Document Type Size
6 EX-101.INS clvs-20170930.xml EX-101.INS 1541176
7 EX-101.SCH clvs-20170930.xsd EX-101.SCH 43737
8 EX-101.CAL clvs-20170930_cal.xml EX-101.CAL 66265
9 EX-101.DEF clvs-20170930_def.xml EX-101.DEF 99405
10 EX-101.LAB clvs-20170930_lab.xml EX-101.LAB 441200
11 EX-101.PRE clvs-20170930_pre.xml EX-101.PRE 291116
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 171172920
SIC: 2834 Pharmaceutical Preparations